| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6495157 | PFIZER | Intravaginal clindamycin ovule composition |
Jul, 2020
(3 years ago) | |
Cleocin is owned by Pfizer.
Cleocin contains Clindamycin Phosphate.
Cleocin has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Cleocin are:
- US6495157
Cleocin was authorised for market use on 13 August, 1999.
Cleocin is available in suppository;vaginal dosage forms.
The generics of Cleocin are possible to be released after 20 July, 2020.
Drugs and Companies using CLINDAMYCIN PHOSPHATE ingredient
Market Authorisation Date: 13 August, 1999
Treatment: NA
Dosage: SUPPOSITORY;VAGINAL
More Information on Dosage
CLEOCIN family patents
